In mouse cardiomyocytes, AS-252424 treatment yielded a lower average intracellular calcium concentration than control. In mouse primary B cells stimulated with αIgM and interleukin-4, AS-252424 had no significant effect on AKT or ERK1/2 phosphorylation compared with diluent control. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Inhibitor Perfusion and Intracellular Calcium in Mouse Cardiomyocytes
Cell-based study · HL-1 cell mouse cardiomyocytes; n = 5, each an average of 25 to 40 cells [1]
HL-1 mouse cardiomyocytes were perfused with the inhibitor at 100 nM. At 15 min, average intracellular calcium in cells displaying oscillating and non-oscillating calcium was 111.9 ± 6.0 nM, compared with control 121.8 ± 4.3 nM (P <0.03).
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 nM
- Exposure duration
- 15 minutes after addition of respective inhibitors
- Method
- perfused
- Vehicle
- DMSO
Methods and source locations
Compound reported in the paper: AS-252424
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Intracellular Ca2+ measurements (S16, S27); Methods > Solutions and chemicals (S40); Figure 4 legend (S92, S97); Table 3 legend (S116); Table 3 (T3.h1, T3.r2)
average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca2+]i: average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca2+]i; comparator: 121.8 ± 4.3 nM — Figure 4 legend (S97); Table 3 (T3.h1, T3.r2)
AKT Phosphorylation in Stimulated Mouse B Cells
Cell-based study · mouse primary B cells [2]
In mouse primary B cells stimulated with αIgM and interleukin-4, AS-252424 at 100 nM, 300 nM, and 1 µM had no significant effect on AKT phosphorylation compared with diluent control.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 nM, 300 nM, and 1 µM
- Exposure duration
- pretreated with inhibitors as indicated for 30 min then activated with 5 µg/mL αIgM + 10 ng/mL interleukin-4 (IL-4) for 1 h before harvest for western blot
- Vehicle
- 0.1% EtOH
- Co-treatment
- Other interventions in this design: αIgM 5 µg/mL; interleukin-4 (IL-4) 10 ng/mL. Compound effect isolated by the comparison: AS-252424 or its diluent control (0.1% EtOH).
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: AS-252424
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Inhibition of p110δ, but Not p110γ, Reduces p-AKT in Activated Mouse B Cells (S5, S7, S9); Figure 1 legend (S100, S101, S103)
phosphorylation of AKT at the serine 473 residue: phosphorylation of AKT at the serine 473 residue; comparator: diluent control (0.1% EtOH) — Results > Inhibition of p110δ, but Not p110γ, Reduces p-AKT in Activated Mouse B Cells (S5, S9); Figure 1 legend (S100, S103)
ERK Phosphorylation in Stimulated Mouse B Cells
Cell-based study · mouse primary B cells [2]
In mouse primary B cells stimulated with αIgM and interleukin-4, AS-252424 at 100 nM, 300 nM, and 1 µM had no significant effect on ERK1/2 phosphorylation compared with diluent control.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 nM, 300 nM, and 1 µM
- Exposure duration
- pretreated with inhibitors as indicated for 30 min then activated with 5 µg/mL αIgM + 10 ng/mL interleukin-4 (IL-4) for 1 h before harvest for western blot
- Vehicle
- 0.1% EtOH
- Co-treatment
- Other interventions in this design: αIgM 5 µg/mL; interleukin-4 (IL-4) 10 ng/mL. Compound effect isolated by the comparison: AS-252424 or its diluent control (0.1% EtOH).
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: AS-252424
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Inhibition of p110δ, but Not p110γ, Reduces p-AKT in Activated Mouse B Cells (S5, S7, S10); Figure 1 legend (S100, S101, S103)
phosphorylation of ERK1/2 on Thr202/Tyr204 residues: phosphorylation of ERK1/2 on Thr202/Tyr204 residues; comparator: diluent control (0.1% EtOH) — Results > Inhibition of p110δ, but Not p110γ, Reduces p-AKT in Activated Mouse B Cells (S5, S10); Figure 1 legend (S100, S103)